Buy Full Version
"Pneumococcal Polysaccharide Vaccine Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Pneumococcal Polysaccharide Vaccine Market by Dosage (Single Dose Vial and Pre-filled Syringe); and End User (Children (2-10 Age), Adults (10-64 Age), and Geriatric (More Than 65 Age)) - Global Opportunities and Industry Forecasts, 2019-2026

Diagnostics and Biotech	LI_184144	Pages: NA	Jan 2020 \| 1194 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age. Pneumococcal polysaccharide vaccine is derived from a capsular polysaccharide. These vaccinations induce specific antibodies, which kills the bacteria by opsonization or phagocytosis.

The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23. However, high costs associated with the development of such vaccines and longer timelines required for pneumonia vaccine production hamper the growth of the global pneumococcal polysaccharide vaccine market. Growing awareness about pneumococcal vaccine and large numbers of mergers & acquisition strategies among key vendors are expected to propel the growth of the market in the near future.

The global pneumococcal polysaccharide vaccine market is segmented on the basis of dosage, end user, and region. On the basis of dosage, the market is segmented into single dose vial and pre-filled syringe. On the basis of end user, the market is segmented into children (2-10 age), adults (10-64 age), and geriatric (more than 65 age). Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Merck & Co., Inc., Pfizer Inc., Glaxosmithkline Plc., Sanofi Pasteur, China National Biotec Group, Astellas Pharma Inc, and Serum Institute of India Pvt. Ltd.

Key Benefits

The study provides an in-depth analysis of the global pneumococcal polysaccharide vaccine market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global pneumococcal polysaccharide vaccine market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global pneumococcal polysaccharide vaccine market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global pneumococcal polysaccharide vaccine market.

Pneumococcal Polysaccharide Vaccine Market Key Segments:

By Dosage

Single Dose Vial
Pre-Filled Syringe

By End User

Children (2-10 Age)
Adult (10-64 Age)
Geriatric (More Than 65 Age)

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Porters Five Forces Analysis
3.3 Market Share Analysis, 2016
3.4 Market Dynamics

3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities

CHAPTER 4 GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET, BY DOSAGE

4.1 Overview
4.2 Market size and forecast
4.3 Single Dose Vial

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Pre-Filled Syringe

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

CHAPTER 5 GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET, BY END USER

5.1 Overview
5.2 Market size and forecast
5.3 Children(2-10 Age)

5.3.1 Market size and forecast

5.4 Adult (10-64 Age)

5.4.1 Market size and forecast

5.5 Geriatric (More Than 65 Age)

5.5.1 Market size and forecast

CHAPTER 6 GLOBAL PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET, BY REGION

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.2.3.1 U.S. market size and forecast
6.2.3.2 Canada market size and forecast
6.2.3.3 Mexico market size and forecast

6.2.4 North America pneumococcal polysaccharide vaccine market by dosage
6.2.5 North America pneumococcal polysaccharide vaccine market by end user

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.3.3.1 Germany market size and forecast
6.3.3.2 France market size and forecast
6.3.3.3 UK market size and forecast
6.3.3.4 Italy market size and forecast
6.3.3.5 Spain market size and forecast
6.3.3.6 Rest of Europe market size and forecast

6.3.4 Europe pneumococcal polysaccharide vaccine market by dosage
6.3.5 Europe pneumococcal polysaccharide vaccine market by end user

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.4.3.1 Japan market size and forecast
6.4.3.2 China market size and forecast
6.4.3.3 India market size and forecast
6.4.3.4 South Korea market size and forecast
6.4.3.5 Rest of Asia-Pacific market size and forecast

6.4.4 Asia-Pacific pneumococcal polysaccharide vaccine market by dosage
6.4.5 Asia-Pacific pneumococcal polysaccharide vaccine market by end user

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.5.3.1 Brazil market size and forecast
6.5.3.2 Saudi Arabia market size and forecast
6.5.3.3 South Africa market size and forecast
6.5.3.4 Rest of LAMEA market size and forecast

6.5.4 LAMEA pneumococcal polysaccharide vaccine market by dosage
6.5.5 LAMEA pneumococcal polysaccharide vaccine market by end user

CHAPTER 7 COMPANY PROFILES

7.1 Merck & Co., Inc.

7.1.1 Overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Operating segment overview
7.1.5 Strategic moves and developments

7.2 Pfizer Inc.

7.2.1 Overview
7.2.2 Company snapshot
7.2.3 Business performance
7.2.4 Operating segment overview
7.2.5 Strategic moves and developments

7.3 GlaxoSmithKline plc.

7.3.1 Overview
7.3.2 Company snapshot
7.3.3 Business performance
7.3.4 Operating segment overview
7.3.5 Strategic moves and developments

7.4 Sanofi Pasteur

7.4.1 Overview
7.4.2 Company snapshot
7.4.3 Business performance
7.4.4 Operating segment overview
7.4.5 Strategic moves and developments

7.5 China National Biotec Group

7.5.1 Overview
7.5.2 Company snapshot
7.5.3 Business performance
7.5.4 Operating segment overview
7.5.5 Strategic moves and developments

7.6 Astellas Pharma Inc

7.6.1 Overview
7.6.2 Company snapshot
7.6.3 Business performance
7.6.4 Operating segment overview
7.6.5 Strategic moves and developments

7.7 Serum Institute of India Pvt. Ltd.

7.7.1 Overview
7.7.2 Company snapshot
7.7.3 Business performance
7.7.4 Operating segment overview
7.7.5 Strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com